PortViewPortView
Argos Therapeutics logo

Argos Therapeutics (ARGS) Stock Analysis

NASDAQHealthcareBiotechnology

$0.27+1.89%
52-week range$0.27
$0.13$3.89

What Argos Therapeutics does

Argos Therapeutics, Inc. (NASDAQ: ARGS) is a Biotechnology company in the Healthcare sector.

Key metrics

Market cap
$0
P/E (TTM)
0.00
Beta
2.47
Dividend yield
0.00%
Revenue / share
$0.20
50-day avg
$1.12
200-day avg
$0.57
52-week high
$3.89
52-week low
$0.13

ETFs linked to ARGS

Broad-market and Healthcare sector ETFs an investor holding Argos Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ARGS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ARGS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Argos Therapeutics?
Argos Therapeutics trades under the ticker ARGS on NASDAQ.
Which exchange is ARGS listed on?
ARGS is listed on NASDAQ.
What sector does Argos Therapeutics operate in?
Argos Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ARGS in a portfolio?
PortView shows ARGS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.